100 related articles for article (PubMed ID: 10473180)
21. Evaluation of in vitro effects of selected physical and chemical agents on detected in Poland Acanthamoeba strains – factors of increasing threats for public health.
Baltaza W; Padzik M; Szaflik JP; Perkowski K; Dybicz M; Chomicz L
Ann Parasitol; 2019; 65(1):19-25. PubMed ID: 31095904
[TBL] [Abstract][Full Text] [Related]
22. In vitro amoebicidal activity of Origanum syriacum and Origanum laevigatum on Acanthamoeba castellanii cysts and trophozoites.
Degerli S; Tepe B; Celiksoz A; Berk S; Malatyali E
Exp Parasitol; 2012 May; 131(1):20-4. PubMed ID: 22417972
[TBL] [Abstract][Full Text] [Related]
23. In-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri.
Schuster FL; Guglielmo BJ; Visvesvara GS
J Eukaryot Microbiol; 2006; 53(2):121-6. PubMed ID: 16579814
[TBL] [Abstract][Full Text] [Related]
24. Development of colorimetric microtiter plate assay for assessment of antimicrobials against Acanthamoeba.
McBride J; Ingram PR; Henriquez FL; Roberts CW
J Clin Microbiol; 2005 Feb; 43(2):629-34. PubMed ID: 15695656
[TBL] [Abstract][Full Text] [Related]
25. Comparative effects of selected azole compounds on trophic and cystic stages of Acanthamoeba polyphaga.
Schuster FL
J Eukaryot Microbiol; 1993; 40(5):563-9. PubMed ID: 8401469
[No Abstract] [Full Text] [Related]
26. Azole Antifungal Agents To Treat the Human Pathogens Acanthamoeba castellanii and Acanthamoeba polyphaga through Inhibition of Sterol 14α-Demethylase (CYP51).
Lamb DC; Warrilow AG; Rolley NJ; Parker JE; Nes WD; Smith SN; Kelly DE; Kelly SL
Antimicrob Agents Chemother; 2015 Aug; 59(8):4707-13. PubMed ID: 26014948
[TBL] [Abstract][Full Text] [Related]
27. Correlation of radical-scavenging capacity and amoebicidal activity of Matricaria recutita L. (Asteraceae).
Hajaji S; Sifaoui I; López-Arencibia A; Reyes-Batlle M; Jiménez IA; Bazzocchi IL; Valladares B; Pinero JE; Lorenzo-Morales J; Akkari H
Exp Parasitol; 2017 Dec; 183():212-217. PubMed ID: 28919332
[TBL] [Abstract][Full Text] [Related]
28. Comparison of chlorhexidine disinfectant in vitro effect on environmental and ocular Acanthamoeba strains, the amoebic agents of human keratitis − an emerging sight-threatening corneal disease in Poland.
Padzik M; Baltaza W; Szaflik JP; Hendiger E; Dybicz M; Chomicz L
Ann Parasitol; 2018; 64(3):229-233. PubMed ID: 30316219
[TBL] [Abstract][Full Text] [Related]
29. Anti-Acanthamoeba activity of Tunisian Thymus capitatus essential oil and organic extracts.
Saoudi S; Sifaoui I; Chammem N; Reyes-Batlle M; López-Arencibia A; Pacheco-Fernández I; Pino V; Hamdi M; Jiménez IA; Bazzocchi IL; Piñero JE; Lorenzo-Morales J
Exp Parasitol; 2017 Dec; 183():231-235. PubMed ID: 28916454
[TBL] [Abstract][Full Text] [Related]
30. Determination of the anti-protozoal activity of medicinal agents using the phenomenon of plaque formation by Acanthamoeba spp.
Shyrobokov V; Poniatovskyi V; Poniatovska V; Romanchyshyna A; Sałamatin R
Ann Parasitol; 2024; 70(1):0. PubMed ID: 38935775
[TBL] [Abstract][Full Text] [Related]
31. In vitro effectiveness of Thymus sipyleus subsp. sipyleus var. sipyleus on Acanthamoeba castellanii and its cytotoxic potential on corneal cells.
Polat ZA; Tepe B; Vural A
Parasitol Res; 2007 Nov; 101(6):1551-5. PubMed ID: 17661186
[TBL] [Abstract][Full Text] [Related]
32. THE USE OF EXTRACTS FROM PASSIFLORA SPP. IN HELPING THE TREATMENT OF ACANTHAMOEBIASIS.
Hadas E; Ozarowski M; Derda M; Thiem B; Cholewinski M; Skrzypczak L; Gryszczynska A; Piasecka A
Acta Pol Pharm; 2017 May; 74(3):921-928. PubMed ID: 29513962
[TBL] [Abstract][Full Text] [Related]
33. Antiamebic activity of aqueous extracts from five medicinal plants from Northeastern Mexico.
Cruz-Vega DE; Aguilar A; Castro-Garza J; González-Garza MT
Arch Med Res; 2000; 31(4 Suppl):S17-8. PubMed ID: 11070206
[No Abstract] [Full Text] [Related]
34. In vitro evaluation of the amoebicidal activity of garlic (Allium sativum) extract on Acanthamoeba castellanii and its cytotoxic potential on corneal cells.
Polat ZA; Vural A; Ozan F; Tepe B; Ozcelik S; Cetin A
J Ocul Pharmacol Ther; 2008 Feb; 24(1):8-14. PubMed ID: 18370873
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and activity of 1H-benzimidazole and 1H-benzotriazole derivatives as inhibitors of Acanthamoeba castellanii.
Kopańska K; Najda A; Zebrowska J; Chomicz L; Piekarczyk J; Myjak P; Bretner M
Bioorg Med Chem; 2004 May; 12(10):2617-24. PubMed ID: 15110843
[TBL] [Abstract][Full Text] [Related]
36. Effect of picroliv on protein and nucleic acid synthesis.
Singh V; Kapoor NK; Dhawan BN
Indian J Exp Biol; 1992 Jan; 30(1):68-9. PubMed ID: 1506022
[TBL] [Abstract][Full Text] [Related]
37. In vitro evaluation of the effectiveness of the macrolide rokitamycin and chlorpromazine against Acanthamoeba castellanii.
Mattana A; Biancu G; Alberti L; Accardo A; Delogu G; Fiori PL; Cappuccinelli P
Antimicrob Agents Chemother; 2004 Dec; 48(12):4520-7. PubMed ID: 15561820
[TBL] [Abstract][Full Text] [Related]
38. Combined drug therapy in the management of granulomatous amoebic encephalitis due to Acanthamoeba spp., and Balamuthia mandrillaris.
Kulsoom H; Baig AM; Siddiqui R; Khan NA
Exp Parasitol; 2014 Nov; 145 Suppl():S115-20. PubMed ID: 24726699
[TBL] [Abstract][Full Text] [Related]
39. Antinociceptive activity of aqueous extract and isolated compounds of Lithrea molleoides.
Morucci F; Lopez P; Miño J; Ferraro G; Gorzalczany S
J Ethnopharmacol; 2012 Jul; 142(2):401-6. PubMed ID: 22609809
[TBL] [Abstract][Full Text] [Related]
40. Cytotoxicity and in vitro susceptibility of Entamoeba histolytica to Morinda morindoides leaf extracts and its isolated constituents.
Cimanga RK; Kambu K; Tona L; Hermans N; Apers S; Totté J; Pieters L; Vlietinck AJ
J Ethnopharmacol; 2006 Aug; 107(1):83-90. PubMed ID: 16603327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
